Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIofina Regulatory News (IOF)

Share Price Information for Iofina (IOF)

Share Price is delayed by 15 minutes
Get Live Data
50.25    -4.00 (-7.55%)
Bid:
49.50
Ask:
51.00
Spread: 1.50 (3.03%)
Market Cap: £94.01m
IOF Live PriceLast checked at - London Stock Exchange

Intraday Iofina Share Chart

Production Update

18 Sep 2014 07:00

RNS Number : 9740R
Iofina PLC
18 September 2014
 

 

September 18, 2014

Iofina plc

("Iofina" or the "Company")

(LSE AIM: IOF)

 

August Production Update

 

 

 

Iofina, specialists in the exploration and production of iodine and iodine specialty chemical derivatives, today updates the market on its production during the month of August and its year end production forecast at its IOsorb® plants.

 

During the month of August, the Company reports that it produced 23.6MT of crystallized iodine compared with 24.5MT in July. A combination of factors including continued fracking, unanticipated design changes at IO#5 and IO#6, and a Salt Water Disposal (SWD) site upgrade by an operator that took longer to complete than forecast resulting in plant downtime, contributed to a decrease in production. These factors had a short-term negative effect on production, with production beginning to normalize in this last week. 

 

All six of the Company's IOsorb® plants are now in operation and producing crystallized iodine, and are expected to produce circa 25-30MT in September with increased exit rates moving forward.

 

The Company has also reviewed its production forecasts for 2014. In light of current fracking schedules, delays in the start of production at IO#5 and IO#6, and lower water volumes after the SWD site upgrade, Iofina anticipates that its overall 2014 crystallized iodine production will be circa 325-350MT of crystallized iodine. This represents close to a 2-fold year over year production increase but is below current market forecasts and managements targets.

 

While the iodine markets continue to remain challenging, Iofina has seen strong demand for its iodide derivatives, due to complete vertical integration and a strong product offering, resulting in the Company's revenues through to September anticipated to surpass the total sales for all of 2013. 

 

Commenting on today's update, President and CEO Dr. Tom Becker stated: "Whilst iodine production year to date has been below our expectations, we are encouraged that iodine production moving forward will show a favourable trend as these new short term items are rectified. We are focused on increasing the output of our current IOsorb® plants which will reduce our cost per kilo."

 

 

For further information, please contact:

Dr. Tom Becker, President and CEO

Iofina

Tel: +44 (0)20 3006 3135

 

John Prior/Rupert Krefting/Paul Gillam

Numis Securities

Tel: +44 (0)20 7260 1000

 

Rob Collins/Emily Morris/Liz Williamson

GMP Securities

Tel: +44(0)20 7647 2800

 

Media Contact:

Dominic Barretto/Anna Legge

Yellow Jersey PR

Tel: +44 (0)7768 537 739

 

 

 

About Iofina:

Iofina specializes in the exploration and production of iodine, iodine specialty chemical derivatives and produced water. Iofina's business strategy is to identify, develop, build, own and operate iodine extraction plants currently focused in North America based on Iofina's WET® IOsorb® technology. Iofina has production operations in the United States, specifically in Texas, Montana, Kentucky and Oklahoma. It has complete vertical integration from the production of iodine in the field to the manufacture of the chemical end-products derived from iodine to the consumer and the recycling of iodine using iodinated side-streams from waste chemical processes in Europe, North America and Asia. Iofina utilizes its portfolio of patented and patent pending technology, proprietary methods and trademarks throughout all business lines.

www.iofina.com

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCKMGMLLNDGDZM
Date   Source Headline
10th Apr 20129:39 amRNSHolding(s) in Company
5th Apr 20128:05 amRNSPurchase of Production Site & Recycling Initiative
2nd Apr 20125:01 pmRNSHolding(s) in Company
29th Mar 201212:11 pmRNSHolding(s) in Company
19th Mar 20127:00 amRNSCorporate Update
25th Nov 20117:00 amRNSDirector/PDMR Shareholding
24th Nov 20117:00 amRNSDirector/PDMR Shareholding
17th Oct 20117:00 amRNSHolding(s) in Company
27th Sep 20117:00 amRNSHalf Yearly Report
9th Aug 20117:00 amRNSTrading Update
30th Jun 20114:42 pmRNSResult of AGM
24th Jun 201111:42 amRNSHolding(s) in Company
8th Jun 20117:00 amRNSAmbrian Partners Appointed Joint Broker to Iofina
7th Jun 20117:00 amRNSIofina Reports Audited Full Year Financials
31st May 20116:03 pmRNSHolding(s) in Company
4th May 20114:32 pmRNSHolding(s) in Company
4th May 20114:29 pmRNSHolding(s) in Company
28th Apr 201112:58 pmRNSHolding(s) in Company
20th Apr 20117:00 amRNSPlacing
13th Apr 20116:28 pmRNSHolding(s) in Company
25th Mar 20117:00 amRNSContract Win
18th Mar 20117:00 amRNSHolding(s) in Company
1st Mar 20113:35 pmRNSHolding(s) in Company
27th Jan 20115:27 pmRNSHolding(s) in Company
12th Jan 20114:40 pmRNSSecond Price Monitoring Extn
12th Jan 20114:35 pmRNSPrice Monitoring Extension
3rd Dec 201012:46 pmRNSOperations Update
19th Oct 20105:30 pmRNSHolding(s) in Company
29th Sep 20109:26 amRNSHolding(s) in Company
28th Sep 20107:01 amRNSInterim Results
28th Sep 20107:00 amRNSAppointment of Finance Director
31st Aug 20107:00 amRNSFourth Extraction and Collection Agreement Signed
16th Jul 20105:57 pmRNSHolding in Company - Replacement
16th Jul 20105:02 pmRNSHoldings in Company
7th Jul 201010:00 amRNSResult of AGM
4th Jun 20107:00 amRNSFinal Results
20th May 20107:00 amRNSNew Agreement Signed and Operations Update
4th May 20107:00 amRNSIssuance of Permit
14th Apr 20107:00 amRNSThird Party Iodine Agreement Signed
22nd Mar 20108:36 amRNSFirst Third Party Iodine Extraction and Collection
22nd Mar 20107:00 amRNSRe Iodine Extraction and Collection Agreement
8th Mar 20107:02 amRNSOperations Update
8th Mar 20107:00 amRNSManagement changes
12th Jan 20103:09 pmRNSDirectorate Change
8th Jan 20107:00 amRNSDirector's Dealings
11th Dec 20096:00 pmRNSHolding in Company
22nd Oct 20095:14 pmRNSChange of Name of Nominated Adviser
19th Oct 20094:07 pmRNSExercise of Options
30th Sep 20097:00 amRNSHalf Yearly Report
10th Aug 200911:13 amRNSManagement Appointments

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.